Suppr超能文献

用99mTc标记抗III型神经微管蛋白单克隆抗体及其与相关抗原的结合

Labelling of the anti-III-neurotubulin monoclonal antibody by 99mTc and its binding to responsible antigen.

作者信息

Slapnicková Katerina, Kolárová Petra, Kynclová Klára

机构信息

UJV NRI Rez, Czech Republic.

出版信息

Nucl Med Rev Cent East Eur. 2007;10(1):1-5.

Abstract

BACKGROUND

beta-III-neurotubulin is a characteristic degradation protein of cellular cytoskeleton of nervous tissues, which originates with disorders that lead to the loss of peripheral neurons or neurons of the central nervous system. For the diagnostics of neuropathic and neurodegenerative processes, beta-III-neurotubulin is therefore the goal structure, and radioactive labelled antibody TU-20 (99m)Tc could theoretically enable diagnostic application in vivo.

MATERIAL AND METHODS

In our case, were selected three ways of labelling monoclonal antibody IgG1-TU-20, which shows a high affinity towards beta-III-neurotubulin with (99m)Tc. The indirect labelling was ensured through the bifunctional chelator HYNIC, the direct labelling by electrolytic means, and the direct labelling of antibody TU-20 reduced by 2-mercaptoethanol. To observe each single feature, the appropriate chemical and biochemical control methods were used. Chemical purity was ensured by gel filtration and, together with chemical stability, it was checked by paper chromatography. To control the biological stability, SDS electrophoresis was used. The immunoreactivity was checked using ELISA-tests.

RESULTS

The results have shown that the optimal method for labelling the antibody TU-20 is indirect labelling through the bifunctional chelator HYNIC, and the least effective method of labelling the antibody TU-20 is reduced by 2-mercaptoethanol.

DISCUSSION

The results of labelling the monoclonal antibody towards antigen TU-20 with (99m)Tc confirmed that structure of the monoclonal antibody is destroyed by 2-mercaptoethanol, and in the case of electrolytic labelling, there are not enough binding places for radionuclide (99m)Tc on the monoclonal antibody.

摘要

背景

β-III-微管蛋白是神经组织细胞骨架的一种特征性降解蛋白,它源于导致外周神经元或中枢神经系统神经元丧失的疾病。因此,对于神经性和神经退行性疾病的诊断,β-III-微管蛋白是目标结构,理论上放射性标记抗体TU-20(99m)Tc可实现体内诊断应用。

材料与方法

在我们的研究中,选择了三种用(99m)Tc标记对β-III-微管蛋白具有高亲和力的单克隆抗体IgG1-TU-20的方法。通过双功能螯合剂HYNIC确保间接标记,通过电解方式进行直接标记,以及用2-巯基乙醇还原抗体TU-20进行直接标记。为观察每个单独的特征,使用了适当的化学和生化控制方法。通过凝胶过滤确保化学纯度,并与化学稳定性一起通过纸色谱法进行检查。为控制生物稳定性,使用了SDS电泳。使用ELISA试验检查免疫反应性。

结果

结果表明,标记抗体TU-20的最佳方法是通过双功能螯合剂HYNIC进行间接标记,而标记抗体TU-20最无效的方法是用2-巯基乙醇还原。

讨论

用(99m)Tc标记针对抗原TU-20的单克隆抗体的结果证实,单克隆抗体的结构被2-巯基乙醇破坏,并且在电解标记的情况下,单克隆抗体上没有足够的放射性核素(99m)Tc结合位点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验